Seeing Is Believing
Currently out of the existing stock ratings of Suji Jeong, 5 are a HOLD (41.67%), 7 are a BUY (58.33%).
Analyst Suji Jeong, currently employed carries an average stock price target met ratio of 50% that have a potential upside of 38.77% achieved within 194 days. Previously, Suji Jeong worked at JEFFERIES.
Suji Jeong’s has documented 24 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PRTK, Paratek Pharmaceuticals at 07-Jun-2023.
Analyst best performing recommendations are on INZY (INOZYME PHARMA ).
The best stock recommendation documented was for INZY (INOZYME PHARMA ) at 3/23/2023. The price target of $6 was fulfilled within 26 days with a profit of $2.7 (81.82%) receiving and performance score of 31.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$14.75
$0.01 (0.07%)
$14.75
1 years 6 months 6 days ago
(15-May-2023)
5/8 (62.5%)
$0.28 (1.94%)
184
Hold
$14.75
$0.01 (0.07%)
$21
1 years 7 months 2 days ago
(19-Apr-2023)
2/4 (50%)
$0.31 (2.15%)
253
Hold
$14.75
$0.01 (0.07%)
$20
1 years 7 months 3 days ago
(18-Apr-2023)
2/3 (66.67%)
$0.31 (2.15%)
349
Hold
$14.75
$0.01 (0.07%)
$15
1 years 7 months 3 days ago
(18-Apr-2023)
1/2 (50%)
$0.31 (2.15%)
69
Buy
$20
$5.26 (35.69%)
$20
1 years 7 months 30 days ago
(22-Mar-2023)
3/7 (42.86%)
$12.23 (157.40%)
615
What Year was the first public recommendation made by Suji Jeong?